NCT01307501View on ClinicalTrials.gov

Safety and Efficacy of Cryoablation for Metastatic Lung Tumors

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 4, 2012

Primary Completion Date

August 30, 2018

Study Completion Date

August 30, 2018

Conditions
Metastatic Lung Cancer
Interventions
DEVICE

Cryoablation

Application of extremely cold temperatures to the identified tumor(s).

Trial Locations (4)

48201

Karmanos Cancer Institute, Detroit

55905

Mayo Clinic Rochester, Rochester

90095

Ronald Regan UCLA Medical Center, Los Angeles

94805

Institut Gustave Roussy, Villejuif

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY

NCT01307501 - Safety and Efficacy of Cryoablation for Metastatic Lung Tumors | Biotech Hunter | Biotech Hunter